BioShares: On March 6, net short sales of 9,500 shares, with a total net sell-off of 10,500 shares over the past 3 days.

Securities Star News: On March 6th, BioShares (600201) had a margin buy-in of 26.6086 million yuan, a margin repayment of 30.6869 million yuan, a net margin sell of 4.0782 million yuan, and a margin balance of 1.561 billion yuan.

Regarding securities lending, on that day, 15,000 shares were sold short, 5,500 shares were repaid, resulting in a net short sale of 9,500 shares. The remaining securities lending balance was 447,800 shares. Over the past three trading days, there has been a continuous net sale totaling 10,500 shares.

The total margin and securities lending balance is 1.568 billion yuan, down 0.24% from yesterday.

Quick Tip

Margin Trading and Securities Lending: An increase in margin balance indicates strengthening bullish market sentiment, while a decrease suggests market hesitation or increased bearish sentiment. Similarly, an increase in securities lending balance indicates growing bearish market sentiment, and a decrease indicates market hesitation or increased bullish sentiment. It’s important to note that due to the financial leverage effect of margin trading and securities lending, they are a double-edged sword for investors—like a magnifying glass. Profits can multiply in favorable conditions, but losses can also be amplified significantly.

The above content is compiled from publicly available information by Securities Star, generated by AI algorithms (Wang Xin Suan Bei 310104345710301240019), and does not constitute investment advice.